Inflammatory bowel disease: The role of commensal microbiome in immune regulation

Ananthakrishnan, 2020, Changing global epidemiology of inflammatory bowel diseases—sustaining healthcare delivery into the 21st century, Clin Gastroenterol Hepatol, 10.1016/j.cgh.2020.01.028 Kotze, 2019, Progression of inflammatory bowel diseases throughout latin America and the Caribbean: a systematic review, Clin Gastroenterol Hepatol, 1 Sarmiento-aguilar, 2019, Incidence and prevalence of in fl ammatory bowel disease in Mexico from a nationwide cohort study in a period of 15 years (2000–2017), Medicine (Baltimore) Ananthakrishnan, 2017, Environmental triggers in IBD: a review of progress and evidence, Nat Publ Gr Zeng, 2019, From genetics to epigenetics roles of epigenetics in inflammatory bowel disease, Front Genet, 10, 1, 10.3389/fgene.2019.01017 Franzosa, 2019, Gut microbiome structure and metabolic activity in inflammatory bowel disease, Nat Microbiol, 4, 293, 10.1038/s41564-018-0306-4 Weaver, 2013, The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin, Annu Rev Pathol Mech, 8, 477, 10.1146/annurev-pathol-011110-130318 Karstelein, 2007, Discovery and biology of IL-23 and IL-27 related but functionally distinct regulators of inflammation, Annu Rev Immunol, 25, 821 Taniguchi K, Wu L, Grivennikov S. A gp130-Src Yap Module links inflammation to epithelial regeneration. Nature. 519:57–62. Uhlig, 2018, Translating immunology into therapeutic concepts for inflammatory bowel disease, Annu Rev Immun, 36, 755, 10.1146/annurev-immunol-042617-053055 Round, 2010, Coordination of tolerogenic immune responses by the commensal microbiota, J Autoimmun, 34, J220, 10.1016/j.jaut.2009.11.007 Tripathi, 2018, The gut–liver axis and the intersection with the microbiome, Nat Rev Gastroenterol Hepatol Thomas, 2017, Primer and perspective for non-microbiologists, Cancer Res, 77, 1783, 10.1158/0008-5472.CAN-16-2929 David, 2013, Gut microbiome, Nature King, 2019, Epithelial–microbial diplomacy: escalating border tensions drive inflammation in inflammatory bowel disease, Intest Res, 17, 177, 10.5217/ir.2018.00170 Richard, 2019, The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases, Nat Rev Gastroenterol Hepatol, 10.1038/s41575-019-0121-2 Kleinschek, 2009, Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation, J Exp Med, 206, 525, 10.1084/jem.20081712 West N, Hegazy A, Owens B. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease. Nature. 23:579–89. Id, 2019, Genetic effects on the commensal microbiota in inflammatory bowel disease patients, PLoS Genet, 1 Parikh, 2019, Colonic epithelial cell diversity in health and inflammatory bowel disease, Nature, 567, 49, 10.1038/s41586-019-0992-y Round, 2010, Inducible Foxp3+regulatory T-cell development by a commensal bacterium of the intestinal microbiota, Proc Natl Acad Sci USA, 2010 Giri, 2019, Secreted microbial metabolites modulate gut immunity and inflammatory tone, biorxiv Ni, 2017, Gut microbiota and IBD: causation or correlation?, Nat Publ Gr, 14, 573 Wagner, 2013, Bacteriophages in gut samples from pediatric crohn's disease patients: metagenomic analysis using 454 pyrosequencing, Inflamm Bowel Dis, 19, 1598, 10.1097/MIB.0b013e318292477c Ananthakrishnan, 2013, A Prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis, Gastroenterology, 1, 10.1016/S0016-5085(13)60001-3 Ijssennagger, 2012, Dietary heme alters microbiota and mucosa of mouse colon without functional changes in host–microbe, PLOS ONE, 7, 10.1371/journal.pone.0049868 Devkota, 2012, Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− mice, Nature, 1 Khalili, 2018, The role of diet in the aetiopathogenesis of inflammatory bowel disease, Nat Rev Gastroenterol Hepatol, 10.1038/s41575-018-0022-9 Sartor, 2017, Roles for intestinal bacteria, virus, and fungi in pathogenesis of inflammatory bowel diseases and therapeutic approaches, Gastroenterology, 152, 327, 10.1053/j.gastro.2016.10.012 Fedorak, 2004, Probiotics and the management of inflammatory bowel disease, Inflamm Bowel Dis, 8, 286, 10.1097/00054725-200405000-00018 Shen, 2014, Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis crohn's disease, and pouchitis: meta-analysis of randomized controlled trials, Inflamm Bowel Dis, 20, 10.1097/01.MIB.0000437495.30052.be Sood, 2009, The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis, Clin Gastroenterol Hepatol, 7, 1202, 10.1016/j.cgh.2009.07.016 Rafieian-kopaei, 2017, Probiotics are a good choice in remission of inflammatory bowel diseases: a meta analysis and systematic review, J Cell Physiol Hye, 2020, Lactobacillus plantarum CBT LP3 ameliorates colitis via modulating T cells in mice, Int J Med Microbiol Pt, 2008, Probiotics for induction of remission in ulcerative colitis (Review) Probiotics for induction of remission in ulcerative colitis, Cochrane, 2007 Bernstein, 2014, 83 Schultz, 2004, Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats, Clin Diagn Lab Immunol, 11, 581 Ishisono, 2019, Dietary fiber pectin ameliorates experimental colitis in a neutral sugar side chain-dependent manner, Front Immunol, 10, 1, 10.3389/fimmu.2019.02979 Furrie, 2005, Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial, Inflamm Bowel Dis, 54, 242 Steed, 2010, Clinical trial: the microbiological and immunological effects of synbiotic consumption – a randomized double-blind placebo-controlled study in active Crohn's disease, Aliment Pharmacol Ther, 10.1111/j.1365-2036.2010.04417.x Altun, 2019, Effects of synbiotic therapy in mild-to-moderately active ulcerative colitis: a randomized placebo-controlled study, Turk J Gastroenterol, 30, 313, 10.5152/tjg.2019.18356 Gevers, 2015, The treatment-naïve microbiome in new-onset Crohn's disease, Cell Host Microbe, 15, 382, 10.1016/j.chom.2014.02.005 Troelsen, 2019, Antibiotic use in childhood and adolescence and risk of inflammatory bowel disease: a case–control study in the UK clinical practice research datalink, Inflamm Bowel Dis, 26, 1 Wang, 2012, Meta-analysis of broad-spectrum antibiotic therapy in patients with active inflammatory bowel disease, Exp Ther Med, 1051, 10.3892/etm.2012.718 Oka, 2020 Cm, 2019, Antibiotics for induction and maintenance of remission in Crohn's disease (Review), Cochrane Singh, 2014, Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis, Gastroenterology, 1 Nguyen, 2019, Treatment and prevention of pouchitis a er ileal pouch-anal anastomosis for chronic ulcerative colitis (Review), Cochrane Dubinsky, 2019, Predominantly antibiotic-resistant intestinal microbiome persists in patients with pouchitis who respond to antibiotic therapy, Gastroenterology Fang, 2018, Protocol for fecal microbiota transplantation in inflammatory bowel disease: a systematic review and meta-analysis, Biomed Res Int, 2018 Imdad, 2018, Fecal transplantation for treatment of inflammatory bowel disease (Review), Cochrane Quraishi, 2020, OP09 Immunomodulatory mechanisms of faecal microbiota transplantation are associated with clinical response in ulcerative colitis: early results from STOP-Colitis, J Crohn's Colitis, 15, S010, 10.1093/ecco-jcc/jjz203.008 Colman, 2015, Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis, J Crohns Colitis, 8, 1569, 10.1016/j.crohns.2014.08.006 Yin, 2019, Systematic review with meta-analysis: review of donor features, procedures and outcomes in 168 clinical studies of faecal microbiota transplantation, Aliment Pharmacol Ther, 1 Ishikawa, 2020, DOP04 Matching between donors and patients in faecal microbiota transplantation is important for long-term maintenance on ulcerative colitis, J Crohn's Colitis, 14, S043, 10.1093/ecco-jcc/jjz203.043 Gogokhia, 2020, A core transferable microbiota in responders to faecal microbiota transplant for ulcerative colitis shape mucosal T-cell immunity, J Crohn's Colitis, 14, S040, 10.1093/ecco-jcc/jjz203.039 Ratner, 2015, Microbial cocktails join fecal transplants in IBD treatment trials, Nat Publ Gr, 33, 787 Sham, 2018, Immune stimulation using a gut microbe-based immunotherapy reduces disease pathology and improves barrier function in ulcerative colitis, Front Immunol, 9, 1, 10.3389/fimmu.2018.02211 Zhu, 2018, Precision editing of the gut microbiota ameliorates colitis, Nat Publ Gr Shi, 2016, Fecal microbiota transplantation for ulcerative colitis: a systematic review and meta-analysis, PLOS ONE, 1 Review, 2016, Fecal microbiota transplantation as a novel therapy for ulcerative colitis, Medicine (Baltimore), 95, 17 Costello, 2017, Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis, Aliment Pharmacol Ther, 10.1111/apt.14173 Paramsothy, 2017, Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis, J Crohn's Colitis, 10.1093/ecco-jcc/jjx063 Narula, 2017, Systematic review and meta-analysis: fecal microbiota transplantation for treatment of active ulcerative colitis, Inflamm Bowel Dis, 1 Cao, 2018, Review article the value of fecal microbiota transplantation in the treatment of ulcerative colitis patients: a systematic review and meta-analysis, Gastroenterol Res Pract, 2018, 10.1155/2018/5480961